Erasca (ERAS) Insider Trading & Ownership $1.74 +0.03 (+1.75%) Closing price 07/25/2025 04:00 PM EasternExtended Trading$1.74 0.00 (-0.29%) As of 07/25/2025 06:55 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Erasca (NASDAQ:ERAS) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage14.40%Number OfInsiders Buying(Last 3 Years)4Amount OfInsider Buying(Last 3 Years)$6.69MNumber OfInsiders Selling(Last 3 Years)0 Get ERAS Insider Trade Alerts Want to know when executives and insiders are buying or selling Erasca stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address ERAS Insider Buying and Selling by Quarter Erasca Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame Start Date End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails5/21/2024Alexander W CasdinDirectorBuy80,000$2.27$181,600.00 12/6/2023Valerie Denise Harding StartDirectorBuy10,000$1.85$18,500.00 12/5/2023Jonathan E LimCEOBuy721,850$1.69$1,219,926.50 12/4/2023Alexander W CasdinDirectorBuy30,000$1.66$49,800.00 10/5/2023Jonathan E LimCEOBuy1,000,000$2.03$2,030,000.00 6/8/2023Jonathan E LimCEOBuy100,000$2.75$275,000.00 4/10/2023Alexander W CasdinDirectorBuy20,000$2.76$55,200.00 3/28/2023Jonathan E LimCEOBuy100,000$2.84$284,000.00 1/10/2023Jonathan E LimCEOBuy60,000$3.86$231,600.00 12/21/2022Valerie Denise Harding StartDirectorBuy10,000$4.64$46,400.00 Get Insider Trades Delivered To Your InboxEnter your email address below to receive a concise daily summary of insider buying activity, insider selling activity and changes in hedge fund holdings. 12/15/2022Alexander W CasdinDirectorBuy20,000$4.87$97,400.00 12/14/2022Jonathan E LimCEOBuy40,000$4.99$199,600.00 12/13/2022Bihua ChenDirectorBuy307,692$6.50$1,999,998.00 (Data available from 1/1/2013 forward) ERAS Insider Trading Activity - Frequently Asked Questions Who is on Erasca's Insider Roster? The list of insiders at Erasca includes Alexander W Casdin, Bihua Chen, Jonathan E Lim, and Valerie Denise Harding Start. Learn more on insiders at ERAS. What percentage of Erasca stock is owned by insiders? 14.40% of Erasca stock is owned by insiders. Learn more on ERAS's insider holdings. Which Erasca insiders have been buying company stock? The following insiders have purchased ERAS shares in the last 24 months: Alexander W Casdin ($231,400.00), Jonathan E Lim ($3,249,926.50), and Valerie Denise Harding Start ($18,500.00). How much insider buying is happening at Erasca? Insiders have purchased a total of 1,841,850 ERAS shares in the last 24 months for a total of $3,499,826.50 bought. Erasca Key ExecutivesDr. Jonathan E. Lim M.D. (Age 52)Co-Founder, Chairman & CEO Compensation: $987.7kDr. David M. Chacko M.D. (Age 40)CFO & Chief Business Officer Compensation: $666.09kMr. Ebun S. Garner Esq. (Age 52)J.D., General Counsel & Corporate Secretary Compensation: $607.44kDr. Michael D. Varney Ph.D. (Age 66)Chairman of Research & Development, Scientific Advisory Board Member and Director Compensation: $86.5kDr. Nik Chetwyn Ph.D.Chief Operating OfficerDr. Lisa Tesvich-Bonora Ph.D.Chief People OfficerMr. Brian L. Baker CPA (Age 57)M.S., Senior Vice President of Finance Ms. Chandra D. Lovejoy M.S. (Age 53)Chief Regulatory Affairs Officer Dr. Robert Shoemaker Ph.D. (Age 43)Senior Vice President of Research Dr. Shannon R. Morris M.D. (Age 54)Ph.D., Chief Medical Officer More Insider Trading Tools from MarketBeat Related Companies Adaptive Biotechnologies Insider Selling Schrodinger Insider Selling Janux Therapeutics Insider Selling 89BIO Insider Selling Vera Therapeutics Insider Selling ANI Pharmaceuticals Insider Selling Biohaven Insider Selling Travere Therapeutics Insider Selling Edgewise Therapeutics Insider Selling Cogent Biosciences Insider Selling Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles The Bottom Is in For These 3 Small-Cap Stocks Insiders Are Buying3 Catalysts Driving Plug Power’s Turnaround CaseInsider Selling Hits Market Leaders—Should You Be Worried?Insiders Spent Millions on These 3 Stocks Over the Past 2 Months3 Small Caps Drawing Insider and Institutional Support This page (NASDAQ:ERAS) was last updated on 7/26/2025 by MarketBeat.com Staff From Our PartnersMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredTrump's 2025 Economic Revolution Is Here Are Your Retirement Savings Ready?Time is short. Trump's reforms may be coming fast—and the financial system roller coaster may be a ride that y...Create New Advertiser | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredCritical AI announcement set to ignite AI 2.0 I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredTrump’s betrayal exposed Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredHIDDEN IN THE BOOK OF GENESIS…“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | Sponsored[Shocking New Report] U.S. Dollar To Crash?The "Death Spiral" Threatening Your Savings But this time, it's not just Dalio ringing the alarm bells…GoldCo Precious Metals | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Erasca, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Erasca With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free ERAS Stock Alerts